Rhonda Farnum, SVP, Comm & Medical Affairs: Theravance Biopharma TBPH Sell · Filed 24/02/22

Trade details

Type: Insider sale
Amount: $10,922.34
Shares · price: 1,254 sh · $8.71 a share
Held after: 311,733 sh
Stock: Theravance Biopharma TBPH
Person: Rhonda FarnumSVP, Comm & Medical Affairs
Trade date: 24/02/22
Filed: 24/02/22
Days to filing: 0 days

Sold 0.4% of holdings

Share of holding sold: 0.4%

Theravance Biopharma trades, last 26 weeks

What else happened in Theravance Biopharma around then

Filed or reported within 30 days of the trade day · 24/01/23~24/03/23

Rhonda Farnum's recent trades

Rhonda FarnumSVP, Comm & Medical Affairs
Planned sale10b5-1 planTheravance Biopharma
Planned sale10b5-1 plan
Theravance Biopharma
TBPH
$226.8K
13,314 sh
$226.8K
Filed 09/15
Traded 09/15
Rhonda FarnumSVP, Comm & Medical Affairs
Sell10b5-1 planTheravance Biopharma
Sell10b5-1 plan
Theravance Biopharma
TBPH
$109.1K
6,657 sh
$109.1K
Filed 06/17
Traded 06/15
Rhonda FarnumSVP, Comm & Medical Affairs
Sell10b5-1 planTheravance Biopharma
Sell10b5-1 plan
Theravance Biopharma
TBPH
$54.6K
3,329 sh
$54.6K
Filed 06/17
Traded 06/15
Rhonda FarnumSVP, Comm & Medical Affairs
Sell10b5-1 planTheravance Biopharma
Sell10b5-1 plan
Theravance Biopharma
TBPH
$54.5K
3,328 sh
$54.5K
Filed 06/17
Traded 06/15
Rhonda FarnumSVP, Comm & Medical Affairs
Planned sale10b5-1 planTheravance Biopharma
Planned sale10b5-1 plan
Theravance Biopharma
TBPH
$218.2K
13,314 sh
$218.2K
Filed 06/15
Traded 06/15